1-sulfonyl-piperdine-3-carboxylic acid amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase for the treatment of type II diabetes mellitus

Details for Australian Patent Application No. 2006222372 (hide)

International Classifications

Event Publications

20 September 2007 PCT application entered the National Phase

PCT publication WO2006/094633 Priority application(s): WO2006/094633

19 November 2009 Application Accepted

Published as AU-B-2006222372

10 December 2009 Corrigenda

Amendments - Amendments Made Under the name F. Hoffman-La Roche AG, Application No. 2006222372, under INID (54) correct the title to read 1-sulfonyl-piperidine-3-carboxylic acid amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase for the treatment of type II diabetes mellitus

17 December 2009 Amendment Made

The nature of the amendment is: Amend the applicant name from F. Hoffman-La Roche AG to F. Hoffmann-La Roche AG

18 March 2010 Standard Patent Sealed

8 April 2010 Corrigenda

Applications Accepted - Name Index Under the name F. Hoffman-La Roche AG, Application No. 2006222372, under INID (54) correct the title to read 1-sulfonyl-piperidine-3-carboxylic acid amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase for the treatment of type II diabetes mellitus

20 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.